BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17034933)

  • 21. Prevention of prostate cancer with finasteride.
    Lee SC; Ellis RJ
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562805
    [No Abstract]   [Full Text] [Related]  

  • 22. Finasteride therapy for benign prostatic hyperplasia.
    Helling TJ
    CMAJ; 2008 Feb; 178(5):596-7. PubMed ID: 18299551
    [No Abstract]   [Full Text] [Related]  

  • 23. The clinical implications of the prostate cancer prevention trial.
    Marberger M; Adolfsson J; Borkowski A; Fitzpatrick J; Kirk D; Prezioso D; Rabaça C; Solsona E; Teillac P
    BJU Int; 2003 Nov; 92(7):667-71. PubMed ID: 14616442
    [No Abstract]   [Full Text] [Related]  

  • 24. Finasteride for prevention of prostate cancer.
    Med Lett Drugs Ther; 2008 Jun; 50(1289):49-50. PubMed ID: 18583946
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of prostate cancer with finasteride.
    Barzell WE
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562803
    [No Abstract]   [Full Text] [Related]  

  • 26. The evolution of the PCPT from clinical to molecular analyses.
    Hoque A
    Nat Clin Pract Oncol; 2006 Nov; 3(11):581. PubMed ID: 17080169
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-Term Effects of Finasteride on Prostate Cancer Mortality.
    Goodman PJ; Tangen CM; Darke AK; Lucia MS; Ford LG; Minasian LM; Parnes HL; LeBlanc ML; Thompson IM
    N Engl J Med; 2019 Jan; 380(4):393-394. PubMed ID: 30673548
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial.
    Walsh PC
    J Urol; 1999 Jan; 161(1):350-1. PubMed ID: 10037436
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of men on finasteride.
    Gormley GJ
    Semin Urol Oncol; 1996 Aug; 14(3):139-44. PubMed ID: 8865475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guideline for 5-alpha-reductase inhibitors in the prevention of prostate cancer is premature.
    Frankel PH; Twardowski P
    J Clin Oncol; 2009 Oct; 27(30):e164; author reply e165. PubMed ID: 19738114
    [No Abstract]   [Full Text] [Related]  

  • 31. The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer.
    Tindall DJ; Rittmaster RS
    J Urol; 2008 Apr; 179(4):1235-42. PubMed ID: 18280514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of prostate cancer. Long-term results of the Prostate Cancer Prevention Trial (PCPT)].
    Michel MS; Nitschmann S; von Hardenberg J
    Internist (Berl); 2014 Aug; 55(8):981-2. PubMed ID: 25027005
    [No Abstract]   [Full Text] [Related]  

  • 33. A role for finasteride in the prevention of prostate cancer?
    LeFevre M
    N Engl J Med; 2013 Aug; 369(7):670-1. PubMed ID: 23944306
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemoprevention of prostate cancer.
    Walsh PC
    N Engl J Med; 2010 Apr; 362(13):1237-8. PubMed ID: 20357287
    [No Abstract]   [Full Text] [Related]  

  • 35. Survival in the prostate cancer prevention trial.
    Revannasiddaiah S; Susheela SP
    N Engl J Med; 2013 Nov; 369(20):1967. PubMed ID: 24224634
    [No Abstract]   [Full Text] [Related]  

  • 36. Survival in the prostate cancer prevention trial.
    Walsh PC
    N Engl J Med; 2013 Nov; 369(20):1967. PubMed ID: 24224633
    [No Abstract]   [Full Text] [Related]  

  • 37. Survival in the prostate cancer prevention trial.
    Tangen CM; Goodman PJ; Thompson IM
    N Engl J Med; 2013 Nov; 369(20):1968. PubMed ID: 24224632
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.
    Etzioni RD; Howlader N; Shaw PA; Ankerst DP; Penson DF; Goodman PJ; Thompson IM
    J Urol; 2005 Sep; 174(3):877-81. PubMed ID: 16093979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of finasteride on risk of prostate cancer: how little we really know.
    Rubin MA; Kantoff PW
    J Cell Biochem; 2004 Feb; 91(3):478-82. PubMed ID: 14755678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventing prostate cancer with finasteride: a mixed blessing.
    Harv Mens Health Watch; 2003 Oct; 8(3):1-3. PubMed ID: 14576014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.